Proteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways

Journal of Translational Medicine

Volumn 7, Issue , 2009, Pages 75-

  Rasheed, Suraiya ^a   Yan, Jasper S ^a   Hussain, Adil ^a   Lai, Bruce ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ALPHAVBETA5 INTEGRIN; ANGIOGENIC FACTOR; CALPHOBINDIN II; CELL ADHESION MOLECULE; CELL PROTEIN; COMPLEMENT RECEPTOR; CRK LIKE PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; FIBRONECTIN; FOCAL ADHESION KINASE 2; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE SYNTHASE; PROTEIN 14 3 3; PROTEIN KINASE C BETA; PROTEIN KINASE ZAP 70; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; SCLEROPROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VON WILLEBRAND FACTOR; ZINC FINGER PROTEIN;

ANGIOGENESIS; ARTICLE; BIOINFORMATICS; CELL CYCLE REGULATION; CELL GROWTH; CELL MEMBRANE; EMBRYO DEVELOPMENT; EXTRACELLULAR MATRIX; GENE SILENCING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; KAPOSI SARCOMA; LYMPHOCYTE ACTIVATION; MASS SPECTROMETRY; MORPHOGENESIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REGENERATION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; T LYMPHOCYTE; VIROGENESIS; VIRUS REPLICATION;

EID: 70350090627     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-7-75     Document Type: Article

References (181)

1. Carmeliet P: Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936.
2. Folkman J: Fundamental concepts of the angiogenic process. Curr Mol Med 2003, 3:643-651.
3. Eming SA, Brachvogel B, Odorisio T, Koch M: Regulation of angiogenesis: wound healing as a model. Prog Histochem Cytochem 2007, 42:115-170.
4. Detmar M: Tumor angiogenesis. J Investig Dermatol Symp Proc 2000, 5:20-23.
5. Tabruyn SP, Griffioen AW: Molecular pathways of angiogenesis inhibition. Biochem Biophys Res Commun 2007, 355:1-5.
6. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31.
7. Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS: Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 2001, 98:1904-1913.
8. Barillari G, Sgadari C, Palladino C, Gendelman R, Caputo A, Morris CB, Nair BC, Markham P, Nel A, Sturzl M, Ensoli B: Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. J Immunol 1999, 163:1929-1935.
9. Sainson RC, Johnston DA, Chu HC, Holderfield MT, Nakatsu MN, Crampton SP, Davis J, Conn E, Hughes CC: TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood 2008, 111:4997-5007.
10. Biswas PS, Banerjee K, Kinchington PR, Rouse BT: Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res 2006, 82:46-54.
11. Arbiser JL: Implications of Epstein-Barr Virus (EBV)-induced carcinogenesis on cutaneous inflammation and carcinogenesis: evidence of recurring patterns of angiogenesis and signal transduction. J Invest Dermatol 2005, 124:xi-xii.
12. Azizan A, Sweat J, Espino C, Gemmer J, Stark L, Kazanis D: Differential proinflammatory and angiogenesis-specific cytokine production in human pulmonary endothelial cells, HPMEC-ST1. J Virol Methods 2006, 138:211-217.
13. Wise LM, Ueda N, Dryden NH, Fleming SB, Caesar C, Roufail S, Achen MG, Stacker SA, Mercer AA: Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor-binding specificities, and the ability to induce vascular permeability yet are uniformly active mitogens. J Biol Chem 2003, 278:38004-38014.
14. Ueda N, Wise LM, Stacker SA, Fleming SB, Mercer AA: Pseudocowpox virus encodes a homolog of vascular endothelial growth factor. Virology 2003, 305:298-309.
15. Psarras S, Volonaki E, Skevaki CL, Xatzipsalti M, Bossios A, Pratsinis H, Tsigkos S, Gourgiotis D, Constantopoulos AG, Papapetropoulos A, Saxoni-Papageorgiou P, Papadopoulos NG: Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses. J Allergy Clin Immunol 2006, 117:291-297.
16. Samaniego F, Markham PD, Gendelman R, Gallo RC, Ensoli B: Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J Immunol 1997, 158:1887-1894.
17. Gallo RC: HIV-1, HHV-8, and Kaposi's sarcoma. J Hum Virol 1998, 1:185-186.
18. Reitz MS Jr, Nerurkar LS, Gallo RC: Perspective on Kaposi's sarcoma: facts, concepts, and conjectures. J Natl Cancer Inst 1999, 91:1453-1458.
19. Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS: Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA 1997, 94:979-984.
20. Masood R, Cesarman E, Smith DL, Gill PS, Flore O: Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. Am J Pathol 2002, 160:23-29.
21. Patsouris E, Korkolopoulou P, Androulaki A, Douzinas E, Kosmopoulou O, Kordossis T: Increased angiogenesis in the bone marrow of HIV-positive patients with myelodysplasia. Pathology 2003, 35:330-335.
22. Mullerat J, Wong Te Fong LF, Davies SE, Winslet MC, Perrett CW: Angiogenesis in anal warts, anal intraepithelial neoplasia and anal squamous cell carcinoma. Colorectal Dis 2003, 5:353-357.
23. Jung de CK, Focchi GR, Martins NV, Gois Speck NM, Baracat EC, Ribalta JC: Angiogenesis in squamous intraepithelial neoplasia of the uterine cervix in HIV-seropositive women. Eur J Gynaecol Oncol 2005, 26:615-618.
24. Dalgleish AG, O'Byrne K: Inflammation and cancer: the role of the immune response and angiogenesis. Cancer Treat Res 2006, 130:1-38.
25. Barillari G, Ensoli B: Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin Microbiol Rev 2002, 15:310-326.
26. Gang EJ, Jeong JA, Han S, Yan Q, Jeon CJ, Kim H: In vitro endothelial potential of human UC blood-derived mesenchymal stem cells. Cytotherapy 2006, 8:215-227.
27. Khodarev NN, Yu J, Labay E, Darga T, Brown CK, Mauceri HJ, Yassari R, Gupta N, Weichselbaum RR: Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. J Cell Sci 2003, 116:1013-1022.
28. Rasheed S, Gottlieb AA, Garry RF: Cell killing by ultraviolet-inactivated human immunodeficiency virus. Virology 1986, 154:395-400.
29. Ringrose JH, Jeeninga RE, Berkhout B, Speijer D: Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. J Virol 2008, 82:4320-4330.
30. Ricardo-Dukelow M, Kadiu I, Rozek W, Schlautman J, Persidsky Y, Ciborowski P, Kanmogne GD, Gendelman HE: HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia. J Neuroimmunol 2007, 185:37-46.
31. Chan EY, Qian WJ, Diamond DL, Liu T, Gritsenko MA, Monroe ME, Camp DG, Smith RD, Katze MG: Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production. J Virol 2007, 81:7571-7583.
32. Coiras M, Camafeita E, Urena T, Lopez JA, Caballero F, Fernandez B, Lopez-Huertas MR, Perez-Olmeda M, Alcami J: Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. Proteomics 2006, 6(Suppl 1):S63-73.
33. Rasheed S, Mao Z, Chan JM, Chan LS: Is Melanoma a stem cell tumor? Identification of neurogenic proteins in trans-differentiated cells. J Transl Med 2005, 3:14.
34. Rasheed S, Yan JS, Lau A, Chan AS: HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study. PLoS ONE 2008, 3:e3003.
35. Lilley KS, Razzaq A, Dupree P: Two-dimensional gel electrophoresis: recent advances in sample preparation, detection and quantitation. Curr Opin Chem Biol 2002, 6:46-50.
36. Huang L, Sankar S, Lin C, Kontos CD, Schroff AD, Cha EH, Feng SM, Li SF, Yu Z, Van Etten RL, Blanar MA, Peters KG: HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity. J Biol Chem 1999, 274:38183-38188.
37. Haffar OK, Smithgall MD, Wong JG, Bradshaw J, Linsley PS: Human immunodeficiency virus type 1 infection of CD4+ T cells down-regulates the expression of CD28: effect on T cell activation and cytokine production. Clin Immunol Immunopathol 1995, 77:262-270.
38. Bangs SC, McMichael AJ, Xu XN: Bystander T cell activation - implications for HIV infection and other diseases. Trends Immunol 2006, 27:518-524.
39. Stefanova I, Saville MW, Peters C, Cleghorn FR, Schwartz D, Venzon DJ, Weinhold KJ, Jack N, Bartholomew C, Blattner WA, Yarchoan R, Bolen JB, Horak ID: HIV infection-induced posttranslational modification of T cell signaling molecules associated with disease progression. J Clin Invest 1996, 98:1290-1297.
40. Sol-Foulon N, Sourisseau M, Porrot F, Thoulouze MI, Trouillet C, Nobile C, Blanchet F, di BV, Noraz N, Taylor N, Alcover A, Hivroz C, Schwartz O: ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse formation. EMBO J 2007, 26:516-526.
41. Hung CH, Thomas L, Ruby CE, Atkins KM, Morris NP, Knight ZA, Scholz I, Barklis E, Weinberg AD, Shokat KM, Thomas G: HIV-1 Nef assembles a Src family kinase-ZAP-70/Syk-PI3K cascade to downregulate cell-surface MHC-I. Cell Host Microbe 2007, 1:121-133.
42. Atkins KM, Thomas L, Youker RT, Harriff MJ, Pissani F, You H, Thomas G: HIV-1 Nef binds PACS-2 to assemble a multikinase cascade that triggers major histocompatibility complex class I (MHC-I) down-regulation: analysis using short interfering RNA and knock-out mice. J Biol Chem 2008, 283:11772-11784.
43. Chan AC, Iwashima M, Turck CW, Weiss A: ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell 1992, 71:649-662.
44. Smolej L, Andrys C, Vroblova V: Modern prognostic factors and angiogenesis in chronic lymphocytic leukemia: more data needed. Leuk Res 2007, 31:1763-1764.
45. Gachard N, Salviat A, Boutet C, Arnoulet C, Durrieu F, Lenormand B, Lepretre S, Olschwang S, Jardin F, Lafage-Pochitaloff M, Penther D, Sainty D, Reminieras L, Feuillard J, Bene MC: Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method. Haematologica 2008, 93:215-223.
46. Huttmann A, Klein-Hitpass L, Thomale J, Deenen R, Carpinteiro A, Nuckel H, Ebeling P, Fuhrer A, Edelmann J, Sellmann L, Duhrsen U, Durig J: Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia 2006, 20:1774-1782.
47. Cannons JL, Lau P, Ghumman B, DeBenedette MA, Yagita H, Okumura K, Watts TH: 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J Immunol 2001, 167:1313-1324.
48. Arch RH, Thompson CB: 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB. Mol Cell Biol 1998, 18:558-565.
49. Seko Y, Takahashi N, Oshima H, Shimozato O, Akiba H, Takeda K, Kobata T, Yagita H, Okumura K, Azuma M, Nagai R: Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3. J Pathol 2001, 195:593-603.
50. Saoulli K, Lee SY, Cannons JL, Yeh WC, Santana A, Goldstein MD, Bangia N, DeBenedette MA, Mak TW, Choi Y, Watts TH: CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J Exp Med 1998, 187:1849-1862.
51. Wang S, Kim YJ, Bick C, Kim SH, Kwon BS: The potential roles of 4-1BB costimulation in HIV type 1 infection. AIDS Res Hum Retroviruses 1998, 14:223-231.
52. Nabors LB, Suswam E, Huang Y, Yang X, Johnson MJ, King PH: Tumor necrosis factor alpha induces angiogenic factor upregulation in malignant glioma cells: a role for RNA stabilization and HuR. Cancer Res 2003, 63:4181-4187.
53. Susal C, Kirschfink M, Kropelin M, Daniel V, Opelz G: Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120. Blood 1996, 87:2329-2336.
54. Stoiber H, Schneider R, Janatova J, Dierich MP: Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1. Immunobiology 1995, 193:98-113.
55. Pruenster M, Wilflingseder D, Banki Z, Ammann CG, Muellauer B, Meyer M, Speth C, Dierich MP, Stoiber H: C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells. Eur J Immunol 2005, 35:2691-2698.
56. Stoiber H, Kacani L, Speth C, Wurzner R, Dierich MP: The supportive role of complement in HIV pathogenesis. Immunol Rev 2001, 180:168-76.
57. Warren J, Ward P: The Inflammatory Response. In Williams Hematology New York: McGraw-Hill; 2003:67-76.
58. Nozaki M, Raisler BJ, Sakurai E, Sarma JV, Barnum SR, Lambris JD, Chen Y, Zhang K, Ambati BK, Baffi JZ, Ambati J: Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA 2006, 103:2328-2333.
59. Hartmann K, Henz BM, Kruger-Krasagakes S, Kohl J, Burger R, Guhl S, Haase I, Lippert U, Zuberbier T: C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997, 89:2863-2870.
60. Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y: HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab 2007, 27:123-134.
61. Meller N, Altman A, Isakov N: New perspectives on PKCtheta, a member of the novel subfamily of protein kinase C. Stem Cells 1998, 16:178-192.
62. Manger B, Weiss A, Imboden J, Laing T, Stobo JD: The role of protein kinase C in transmembrane signaling by the T cell antigen receptor complex. J Immunol 1987, 139:2755-2760.
63. Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L, Sozzani S, Mantovani A, Altruda F, Wymann MP: Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000, 287:1049-1053.
64. Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, Bolon B, Wakeham A, Itie A, Bouchard D, Kozieradzki I, Joza N, Mak TW, Ohashi PS, Suzuki A, Penninger JM: Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 2000, 287:1040-1046.
65. Borgatti P, Zauli G, Colamussi ML, Gibellini D, Previati M, Cantley LL, Capitani S: Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells. Eur J Immunol 1997, 27:2805-2811.
66. Wheeler M, Domin J: Recruitment of the class II phosphoinositide 3-kinase C2beta to the epidermal growth factor receptor: role of Grb2. Mol Cell Biol 2001, 21:6660-6667.
67. Im E, Kazlauskas A: Regulating angiogenesis at the level of PtdIns-4,5-P2. EMBO J 2006, 25:2075-2082.
68. Mataki C, Murakami T, Umetani M, Wada Y, Ishii M, Tsutsumi S, Aburatani H, Hamakubo T, Kodama T: A novel zinc finger protein mRNA in human umbilical vein endothelial cells is profoundly induced by tumor necrosis factor alpha. J Atheroscler Thromb 2000, 7:97-103.
69. Murakami T, Mataki C, Nagao C, Umetani M, Wada Y, Ishii M, Tsutsumi S, Kohro T, Saiura A, Aburatani H, Hamakubo T, Kodama T: The gene expression profile of human umbilical vein endothelial cells stimulated by tumor necrosis factor alpha using DNA microarray analysis. J Atheroscler Thromb 2000, 7:39-44.
70. Lee-Huang S, Zhang L, Huang PL, Chang YT, Huang PL: Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment. Biochem Biophys Res Commun 2003, 307:1029-1037.
71. Mochan TA, Venere M, DiTullio RA Jr, Halazonetis TD: 53BP1, an activator of ATM in response to DNA damage. DNA Repair (Amst) 2004, 3:945-952.
72. Graf T: In vitro transformation of chicken bone marrow cells with avian erythroblastosis virus. Z Naturforsch [C] 1975, 30:847-849.
73. Chen QQ, Chen XY, Jiang YY, Liu J: Identification of novel nuclear localization signal within the ErbB-2 protein. Cell Res 2005, 15:504-510.
74. Navolanic PM, Steelman LS, McCubrey JA: EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review). Int J Oncol 2003, 22:237-252.
75. Negro A, Brar BK, Lee KF: Essential roles of Her2/erbB2 in cardiac development and function. Recent Prog Horm Res 2004, 59:1-12.
76. Russell KS, Stern DF, Polverini PJ, Bender JR: Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis. Am J Physiol 1999, 277:H2205-H2211.
77. Beckers J, Herrmann F, Rieger S, Drobyshev AL, Horsch M, Hrabe de AM, Seliger B: Identification and validation of novel ERBB2 (HER2, NEU) targets including genes involved in angiogenesis. Int J Cancer 2005, 114:590-597.
78. Bueter W, Dammann O, Zscheppang K, Korenbaum E, Dammann CE: ErbB receptors in fetal endothelium - a potential linkage point for inflammation-associated neonatal disorders. Cytokine 2006, 36:267-275.
79. Zhang S, Weinheimer C, Courtois M, Kovacs A, Zhang CE, Cheng AM, Wang Y, Muslin AJ: The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J Clin Invest 2003, 111:833-841.
80. Laramee M, Chabot C, Cloutier M, Stenne R, Holgado-Madruga M, Wong AJ, Royal I: The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation. J Biol Chem 2007, 282:7758-7769.
81. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B: Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 1995, 92:4838-4842.
82. Papadopoulos GK, Ouzounis C, Eliopoulos E: RGD sequences in several receptor proteins: novel cell adhesion function of receptors? Int J Biol Macromol 1998, 22:51-57
83. Fiorelli V, Gendelman R, Sirianni MC, Chang HK, Colombini S, Markham PD, Monini P, Sonnabend J, Pintus A, Gallo RC, Ensoli B: gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood 1998, 91:956-967
84. Rusnati M, Urbinati C, Musulin B, Ribatti D, Albini A, Noonan D, Marchisone C, Waltenberger J, Presta M: Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein. Endothelium 2001, 8:65-74.
85. Rubio DA, Canadi J, Weiglhofer W, Scheidegger P, Jaussi R, Kurt BH: HIV TAT basic peptide is not a high-affinity ligand for VEGF receptor 2. Biol Chem 2003, 384:1435-1441.
86. Dreesen O, Brivanlou AH: Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev 2007, 3:7-17.
87. Lee KF, Simon H, Chen H, Bates B, Hung MC, Hauser C: Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 1995, 378:394-398.
88. Nokta MA, Hassan MI, Morgan JA, Loesch KA, Pollard RB: Protein kinase C and intracellular free Ca++: relationship to human immunodeficiency virus (HIV)-induced cellular hyporesponsiveness. Proc Soc Exp Biol Med 1994, 207:284-291.
89. Ali AS, Ali S, El-Rayes BF, Philip PA, Sarkar FH: Exploitation of protein kinase C: A useful target for cancer therapy. Cancer Treat Rev 2008, 35:1-8.
90. Way KJ, Katai N, King GL: Protein kinase C and the development of diabetic vascular complications. Diabet Med 2001, 18:945-959.
91. Klint P, Kanda S, Kloog Y, Claesson-Welsh L: Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation. Oncogene 1999, 18:3354-3364.
92. Mason JC, Lidington EA, Ahmad SR, Haskard DO: bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction. Am J Physiol Cell Physiol 2002, 282:C578-C587.
93. Mountain DJ, Singh M, Singh K: Downregulation of VEGF-D expression by interleukin-1beta in cardiac microvascular endothelial cells is mediated by MAPKs and PKCalpha/ beta1. J Cell Physiol 2008, 215:337-343.
94. Kim J, Choi YL, Vallentin A, Hunrichs BS, Hellerstein MK, Peehl DM, Mochly-Rosen D: Centrosomal PKCbetaII and pericentrin are critical for human prostate cancer growth and angiogenesis. Cancer Res 2008, 68:6831-6839.
95. Sledge GW Jr, Gokmen-Polar Y: Protein kinase C-beta as a therapeutic target in breast cancer. Semin Oncol 2006, 33:S15-S18.
96. Desai J, Shannon ME, Johnson MD, Ruff DW, Hughes LA, Kerley MK, Carpenter DA, Johnson DK, Rinchik EM, Culiat CT: Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects. Hum Mol Genet 2006, 15:1329-1341.
97. Watanabe TK, Katagiri T, Suzuki M, Shimizu F, Fujiwara T, Kanemoto N, Nakamura Y, Hirai Y, Maekawa H, Takahashi E: Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats. Genomics 1996, 38:273-276.
98. Camors E, Monceau V, Charlemagne D: Annexins and Ca2+ handling in the heart. Cardiovasc Res 2005, 65:793-802.
99. Garcia VE, Chuluyan HE: SLAM and CD31: Signaling molecules involved in cytokine secretion during the development of innate and adaptive immune responses. Cytokine Growth Factor Rev 2007, 18:85-96.
100. Alfonso P, Dolado I, Swat A, Nunez A, Cuadrado A, Nebreda AR, Casal JI: Proteomic analysis of p38alpha mitogen-activated protein kinase-regulated changes in membrane fractions of RAS-transformed fibroblasts. Proteomics 2006, 6(Suppl 1):S262-71.
101. Rentero C, Evans R, Wood P, Tebar F, Vila de MS, Cubells L, de DI, Hayes TE, Hughes WE, Pol A, Rye KA, Enrich C, Grewal T: Inhibition of H-Ras and MAPK is compensated by PKC-dependent pathways in annexin A6 expressing cells. Cell Signal 2006, 18:1006-1016.
102. Schmitz-Peiffer C, Browne CL, Walker JH, Biden TJ: Activated protein kinase C alpha associates with annexin VI from skeletal muscle. Biochem J 1998, 330(Pt 2):675-681.
103. Juengel JL, Melner MH, Clapper JA, Turzillo AM, Moss GE, Nett TM, Niswender GD: Steady-state concentrations of mRNA encoding two inhibitors of protein kinase C in ovine luteal tissue. J Reprod Fertil 1998, 113:299-305.
104. Toker A, Sellers LA, Amess B, Patel Y, Harris A, Aitken A: Multiple isoforms of a protein kinase C inhibitor (KCIP-1/14-3-3) from sheep brain. Eur J Biochem 1992, 206:453-461.
105. Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, Kulkarni S, Metalnikov P, O'Donnell P, Taylor P, Taylor L, Zougman A, Woodgett JR, Langeberg LK, Scott JD, Pawson T: Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 2004, 14:1436-1450.
106. Autieri MV, Carbone CJ: 14-3-3Gamma interacts with and is phosphorylated by multiple protein kinase C isoforms in PDGF-stimulated human vascular smooth muscle cells. DNA Cell Biol 1999, 18:555-564.
107. Depeille PE, Ding Y, Bromberg-White JL, Duesbery NS: MKK signaling and vascularization. Oncogene 2007, 26:1290-1296.
108. Chang L, Karin M: Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
109. Greenway A, Azad A, Mills J, McPhee D: Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogenactivated protein kinase, inhibiting kinase activity. J Virol 1996, 70:6701-6708.
110. Yang X, Gabuzda D: Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J Virol 1999, 73:3460-3466.
111. Bukrinskaya AG, Ghorpade A, Heinzinger NK, Smithgall TE, Lewis RE, Stevenson M: Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc Natl Acad Sci USA 1996, 93:367-371.
112. Toschi E, Bacigalupo I, Strippoli R, Chiozzini C, Cereseto A, Falchi M, Nappi F, Sgadari C, Barillari G, Mainiero F, Ensoli B: HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway. Mol Biol Cell 2006, 17:1985-1994.
113. Ganju RK, Munshi N, Nair BC, Liu ZY, Gill P, Groopman JE: Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. J Virol 1998, 72:6131-6137.
114. Mavria G, Vercoulen Y, Yeo M, Paterson H, Karasarides M, Marais R, Bird D, Marshall CJ: ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis. Cancer Cell 2006, 9:33-44.
115. Wang Y, Sheibani N: PECAM-1 isoform-specific activation of MAPK/ERKs and small GTPases: implications in inflammation and angiogenesis. J Cell Biochem 2006, 98:451-468.
116. Pullikuth AK, Catling AD: Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: A perspective. Cell Signal 2007, 19:1621-1632.
117. Tao J, Malbon CC: G-protein-coupled receptor-associated Akinase anchoring proteins AKAP5 and AKAP12: differential signaling to MAPK and GPCR recycling. J Mol Signal 2008, 3:19.
118. Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, Xu G, Li JL, Prasad KV, Griffin JD: The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway. Oncogene 1996, 12:839-846.
119. Yeo MG, Sung BH, Oh HJ, Park ZY, Marcantonio EE, Song WK: Focal adhesion targeting of v-Crk is essential for FAK phosphorylation and cell migration in mouse embryo fibroblasts deficient src family kinases or p130CAS. J Cell Physiol 2008, 214:604-613.
120. Sung BH, Yeo MG, Oh HJ, Song WK: v-Crk induces Rac-dependent membrane ruffling and cell migration in CAS-deficient embryonic fibroblasts. Mol Cells 2008, 25:131-137.
121. Feller SM, Posern G, Voss J, Kardinal C, Sakkab D, Zheng J, Knudsen BS: Physiological signals and oncogenesis mediated through Crk family adapter proteins. J Cell Physiol 1998, 177:535-552.
122. Watanabe T, Tsuda M, Makino Y, Ichihara S, Sawa H, Minami A, Mochizuki N, Nagashima K, Tanaka S: Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines. Mol Cancer Res 2006, 4:499-510.
123. Luttrell LM: Transmembrane signaling by G protein-coupled receptors. Methods Mol Biol 2006, 332:3-49.
124. Kristiansen K: Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 2004, 103:21-80.
125. Koh JT, Kook H, Kee HJ, Seo YW, Jeong BC, Lee JH, Kim MY, Yoon KC, Jung S, Kim KK: Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking alphavbeta5 integrin. Exp Cell Res 2004, 294:172-184.
126. Kee HJ, Ahn KY, Choi KC, Won SJ, Heo T, Jung S, Kim JK, Bae CS, Kim KK: Expression of brain-specific angiogenesis inhibitor 3 (BAI3) in normal brain and implications for BAI3 in ischemia-induced brain angiogenesis and malignant glioma. FEBS Lett 2004, 569:307-316.
127. Zohrabian VM, Nandu H, Gulati N, Khitrov G, Zhao C, Mohan A, Demattia J, Braun A, Das K, Murali R, Jhanwar-Uniyal M: Gene expression profiling of metastatic brain cancer. Oncol Rep 2007, 18:321-328.
128. Mori K, Kanemura Y, Fujikawa H, Nakano A, Ikemoto H, Ozaki I, Matsumoto T, Tamura K, Yokota M, Arita N: Brain-specific angiogenesis inhibitor 1 (BAI1) is expressed in human cerebral neuronal cells. Neurosci Res 2002, 43:69-74.
129. Nishimori H, Shiratsuchi T, Urano T, Kimura Y, Kiyono K, Tatsumi K, Yoshida S, Ono M, Kuwano M, Nakamura Y, Tokino T: A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 1997, 15:2145-2150.
130. Su SC, Mendoza EA, Kwak HI, Bayless KJ: Molecular profile of endothelial invasion of three-dimensional collagen matrices: insights into angiogenic sprout induction in wound healing. Am J Physiol Cell Physiol 2008, 295:C1215-C1229.
131. Bodary SC, McLean JW: The integrin beta 1 subunit associates with the vitronectin receptor alpha v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem 1990, 265:5938-5941.
132. Wissing J, Jansch L, Nimtz M, Dieterich G, Hornberger R, Keri G, Wehland J, Daub H: Proteomics Analysis of Protein Kinases by Target Class-selective Prefractionation and Tandem Mass Spectrometry. Mol Cell Proteomics 2007, 6:537-547.
133. Li X, Dy RC, Cance WG, Graves LM, Earp HS: Interactions between two cytoskeleton-associated tyrosine kinases: calcium-dependent tyrosine kinase and focal adhesion tyrosine kinase. J Biol Chem 1999, 274:8917-8924.
134. Mitra SK, Mikolon D, Molina JE, Hsia DA, Hanson DA, Chi A, Lim ST, Bernard-Trifilo JA, Ilic D, Stupack DG, Cheresh DA, Schlaepfer DD: Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors. Oncogene 2006, 25:5969-5984.
135. Liu ZY, Ganju RK, Wang JF, Schweitzer K, Weksler B, Avraham S, Groopman JE: Characterization of signal transduction pathways in human bone marrow endothelial cells. Blood 1997, 90:2253-2259.
136. Avraham HK, Jiang S, Lee TH, Prakash O, Avraham S: HIV-1 Tatmediated effects on focal adhesion assembly and permeability in brain microvascular endothelial cells. J Immunol 2004, 173:6228-6233.
137. Tang H, Hao Q, Fitzgerald T, Sasaki T, Landon EJ, Inagami T: Pyk2/ CAKbeta tyrosine kinase activity-mediated angiogenesis of pulmonary vascular endothelial cells. J Biol Chem 2002, 277:5441-5447.
138. Tazaki T, Miyazaki K, Hiyama E, Nakamoto T, Sakai R, Yamasaki N, Honda Z, Noda M, Miyasaka N, Sueda T, Honda H: Functional analysis of Src homology 3-encoding exon (exon 2) of p130Cas in primary fibroblasts derived from exon 2-specific knockout mice. Genes Cells 2008, 13:145-157.
139. Pedchenko V, Zent R, Hudson BG: Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha3 chain of type IV collagen: implication for the mechanism of endothelia cell adhesion. J Biol Chem 2004, 279:2772-2780.
140. Wijelath ES, Murray J, Rahman S, Patel Y, Ishida A, Strand K, Aziz S, Cardona C, Hammond WP, Savidge GF, Rafii S, Sobel M: Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 2002, 91:25-31.
141. Zhou X, Rowe RG, Hiraoka N, George JP, Wirtz D, Mosher DF, Virtanen I, Chernousov MA, Weiss SJ: Fibronectin fibrillogenesis regulates three-dimensional neovessel formation. Genes Dev 2008, 22:1231-1243.
142. Strachan LR, Condic ML: Neural crest motility on fibronectin is regulated by integrin activation. Exp Cell Res 2008, 314:441-452.
143. Liu J, He X, Corbett SA, Lowry SF, Graham AM, Fassler R, Li S: Integrins are required for the differentiation of visceral endoderm. J Cell Sci 2009, 122:233-242.
144. Meyer A, Auernheimer J, Modlinger A, Kessler H: Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting. Curr Pharm Des 2006, 12:2723-2747.
145. Carlson TR, Hu H, Braren R, Kim YH, Wang RA: Cell-autonomous requirement for beta1 integrin in endothelial cell adhesion, migration and survival during angiogenesis in mice. Development 2008, 135:2193-2202.
146. Adelsman MA, McCarthy JB, Shimizu Y: Stimulation of beta1-integrin function by epidermal growth factor and heregulinbeta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase. Mol Biol Cell 1999, 10:2861-2878.
147. Murohara T, Witzenbichler B, Spyridopoulos I, Asahara T, Ding B, Sullivan A, Losordo DW, Isner JM: Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 1999, 19:1156-1161.
148. Caselli A, Camici G, Manao G, Moneti G, Pazzagli L, Cappugi G, Ramponi G: Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase. J Biol Chem 1994, 269:24878-24882.
149. Colognato H, Yurchenco PD: Form and function: the laminin family of heterotrimers. Dev Dyn 2000, 218:213-234.
150. Rebustini IT, Patel VN, Stewart JS, Layvey A, Georges-Labouesse E, Miner JH, Hoffman MP: Laminin alpha5 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through beta1 integrin signaling. Dev Biol 2007, 308:15-29.
151. Li S, Harrison D, Carbonetto S, Fassler R, Smyth N, Edgar D, Yurchenco PD: Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation. J Cell Biol 2002, 157:1279-1290.
152. Barillari G, Sgadari C, Fiorelli V, Samaniego F, Colombini S, Manzari V, Modesti A, Nair BC, Cafaro A, Sturzl M, Ensoli B: The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood 1999, 94:663-672.
153. Sudhakaran PR, Viji RI, Kiran MS, Sameer KV: Endothelial cell-laminin interaction: modulation of LDH expression involves alpha(6)beta (4) integrin-FAK-p38MAPK pathway. Glycoconj J 2008, 26:697-704.
154. Pollard SM, Parsons MJ, Kamei M, Kettleborough RN, Thomas KA, Pham VN, Bae MK, Scott A, Weinstein BM, Stemple DL: Essential and overlapping roles for laminin alpha chains in notochord and blood vessel formation. Dev Biol 2006, 289:64-76.
155. Matarrese P, Conti L, Varano B, Gauzzi MC, Belardelli F, Gessani S, Malorni W: The HIV-1 vpr protein induces anoikis-resistance by modulating cell adhesion process and microfilament system assembly. Cell Death Differ 2000, 7:25-36.
156. Zhang Y, Sivasankar S, Nelson WJ, Chu S: Resolving cadherin interactions and binding cooperativity at the single-molecule level. PNAS 2009, 106:109-114.
157. Krishna K, Redies C: Expression of cadherin superfamily genes in brain vascular development. J Cereb Blood Flow Metab 2009, 29:224-229.
158. Katoh Y, Katoh M: Comparative intergenomics on FAT1, FAT2, FAT3 and FAT4. Int J Mol Med 2006, 18:523-528.
159. Obata S, Sago H, Mori N, Rochelle JM, Seldin MF, Davidson M, St JT, Taketani S, Suzuki ST: Protocadherin Pcdh2 shows properties similar to, but distinct from, those of classical cadherins. J Cell Sci 1995, 108:3765-3773.
160. Mahoney PA, Weber U, Onofrechuk P, Biessmann H, Bryant PJ, Goodman CS: The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily. Cell 1991, 67:853-868.
161. Ahn J, Febbraio M, Silverstein RL: A novel isoform of human Golgi complex-localized glycoprotein-1 (also known as Eselectin ligand-1, MG-160 and cysteine-rich fibroblast growth factor receptor) targets differential subcellular localization. J Cell Sci 2005, 118:1725-1731.
162. Steegmaier M, Borges E, Berger J, Schwarz H, Vestweber D: The Eselectin-ligand ESL-1 is located in the Golgi as well as on microvilli on the cell surface. J Cell Sci 1997, 110:687-694.
163. Verin AD, Lazar V, Torry RJ, Labarrere CA, Patterson CE, Garcia JG: Expression of a novel high molecular-weight myosin light chain kinase in endothelium. Am J Respir Cell Mol Biol 1998, 19:758-766.
164. Potier MC, Chelot E, Pekarsky Y, Gardiner K, Rossier J, Turnell WG: The human myosin light chain kinase (MLCK) from hippocampus: cloning, sequencing, expression, and localization to 3qcen-q21. Genomics 1995, 29:562-570.
165. Tang BL, Hong W: ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. FEBS Lett 1999, 445:223-225.
166. Clark ME, Kelner GS, Turbeville LA, Boyer A, Arden KC, Maki RA: ADAMTS9, a novel member of the ADAM-TS/metallospondin gene family. Genomics 2000, 67:343-350.
167. Porter S, Clark IM, Kevorkian L, Edwards DR: The ADAMTS metalloproteinases. Biochem J 2005, 386:15-27.
168. Zeng W, Corcoran C, Collins-Racie LA, Lavallie ER, Morris EA, Flannery CR: Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5,-9, -16 and -18. Biochim Biophys Acta 2006, 1760:517-524.
169. Demircan K, Hirohata S, Nishida K, Hatipoglu OF, Oohashi T, Yonezawa T, Apte SS, Ninomiya Y: ADAMTS-9 is synergistically induced by interleukin-1beta and tumor necrosis factor alpha in OUMS-27 chondrosarcoma cells and in human chondrocytes. Arthritis Rheum 2005, 52:1451-1460.
170. Little CB, Flannery CR, Hughes CE, Mort JS, Roughley PJ, Dent C, Caterson B: Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 1999, 344(Pt 1):61-8.
171. Streit M, Riccardi L, Velasco P, Brown LF, Hawighorst T, Bornstein P, Detmar M: Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci USA 1999, 96:14888-14893.
172. Iruela-Arispe ML, Luque A, Lee N: Thrombospondin modules and angiogenesis. Int J Biochem Cell Biol 2004, 36:1070-1078.
173. Stauber WT, Fritz VK, Dahlmann B: Extracellular matrix changes following blunt trauma to rat skeletal muscles. Exp Mol Pathol 1990, 52:69-86.
174. Zwirner J, Werfel T, Wilken HC, Theile E, Gotze O: Anaphylatoxin C3a but not C3a(desArg) is a chemotaxin for the mouse macrophage cell line J774. Eur J Immunol 1998, 28:1570-1577.
175. Bodnar RJ, Xi X, Li Z, Berndt MC, Du X: Regulation of glycoprotein Ib-IX-von Willebrand factor interaction by cAMPdependent protein kinase-mediated phosphorylation at Ser 166 of glycoprotein Ib(beta). J Biol Chem 2002, 277:47080-47087.
176. Sumpio BE, Riley JT, Dardik A: Cells in focus: endothelial cell. Int J Biochem Cell Biol 2002, 34:1508-1512.
177. Kessler L, Wiesel ML, Attali P, Mossard JM, Cazenave JP, Pinget M: Von Willebrand factor in diabetic angiopathy. Diabetes Metab 1998, 24:327-336.
178. Reininger AJ: VWF attributes-impact on thrombus formation. Thromb Res 2008, 122(Suppl 4):S9-13.
179. Francisci D, Giannini S, Baldelli F, Leone M, Belfiori B, Guglielmini G, Malincarne L, Gresele P: HIV type 1 infection, and not shortterm HAART, induces endothelial dysfunction. AIDS 2009, 23(5):589-596.
180. Li Z, Xi X, Gu M, Feil R, Ye RD, Eigenthaler M, Hofmann F, Du X: A stimulatory role for cGMP-dependent protein kinase in platelet activation. Cell 2003, 112:77-86.
181. Drouet L, Scrobohaci ML, Janier M, Baudin B: Endothelial cells: target for the HIV1 virus? Nouv Rev Fr Hematol 1990, 32:103-106